In the ongoing battle against drug-resistant infections, the development of new antibiotics is crucial for modern medicine.With antibiotic resistance on the rise, innovative solutions like those being pioneered by Kinvard Bio, a Harvard startup, offer hope for treating diseases that once seemed manageable.